Cell Homing – The New Age Therapy in Regenerative Endodontics | Book Publisher International

Root canal therapy or apexification is the standard treatment for teeth that are irreversibly diseased or necrotic. By attempting to repair the injured "pulp-like" tissue, regenerative endodontics can prevent necrosis and maintain the vitality of the teeth.  The main clinical benefit is the development of root. The term "pulp-like" tissue does not relate to pulp-dentin complex development or regenerated pulp tissue with an odontoblastic layer.

The ability of endogenous stem cells to regenerate tissue is the foundation of the cell homing technology. The term "cell homing" describes the migration or infiltration of endogenous cells into the cite in response to physiological, biochemical, or biological stimuli, or through passive flow in the form of a blood clot from the apical tissue. The American Association of Endodontists has established its success criteria for Regenerative Endodontic Procedures. Despite difficulties, Heet al. (2017) found that cell homing is now the most clinically viable method for dental pulp regeneration. Future advancements in tissue engineering could lead to new scaffold designs, antibacterial protocols, and the use of other signalling molecules, improving the outcome's predictability. This review study aims to provide a summary of cell homing as well as a number of strategies for encouraging the regeneration of damaged pulp.

Author(s) Details:

R Sumukh Bharadwaj,
Department of Conservative Dentistry & Endodontics, JSS Dental College & Hospital, Mysuru, India.

Ashwini Tumkur Shivakumar,
Department of Conservative Dentistry & Endodontics, JSS Dental College & Hospital, Mysuru, India.

Sowmya Halasabalu Kalgeri,
Department of Conservative Dentistry & Endodontics, JSS Dental College & Hospital, Mysuru, India.

Adarsh Choudhary,
Department of Oral & Maxillofacial Surgery, JSS Dental College & Hospital, Mysuru, India.

Prajwal M S,
Department of Oral & Maxillofacial Surgery, JSS Dental College & Hospital, Mysuru, India.

Supreeth S Gowda,
Department of Conservative Dentistry & Endodontics, JSS Dental College & Hospital, Mysuru, India.

Please see the link here: https://stm.bookpi.org/CHTNATRE/article/view/13557

Estimation of Cellular Content in Second-Generation Solid Fibrin Concentrates (PRFs)| Chapter 6 | Cutting Edge Research in Biology Vol. 4

 We acted a study to judge the amount of Platelets and Leukocytes directly-production hard platelet concentrates in conditions of Sensitivity, Specificity, Positive Predictive Value (VP+), Negative Predictive Value (VP-), False Negative Proportion, and False Positive Proportion of our Statistical Method. Blood was composed in anticoagulant-free PET tubes accompanying silica for clot result and PRF membranes. The membranes and clots presented were checked. In a premature work, the authors, offset from the results acquired in Kitamura's work, cherished to evolve an smooth and modest order to reckon the exact amount of platelets and leukocytes held in PRF, distinguished to the individual present in unmodified blood, offset from a plain "haemochromocytometric test". In this study, the authors have judged the Sensitivity, Specificity, Positive Predictive Value (VP+), Negative Predictive Value (VP-), False Negative Proportion, and False Positive Proportion of the "Statistical Method". Using the Statistical Method, we have this result by lowering by 34.12% (±28.2) the profit of leukocytes got from the CBC test. We acquired the profit of leukocytes held in the PRF sheath by t-PA digesting and by lowering by 15.12% (±24.87) the worth of platelets got for one alike arrangement, we have attained the profit held in dimensional platelet concentrates by t-PA digesting. The projected order confirmed a Se=0.75; Sp=0.86; VP+=0.75; VP-=0.86 for platelet counts, Se=0.47; Sp=0.66; VP+=0.80; VP-=0.30 for blood corpuscle counts. Conclusion: Our study reliable to similar the PRF arrangement process by approving a mathematical arrangement to reckon the exact amount of platelets and leukocytes in second-era dependable platelet concentrates, making it smooth to judge individual PRF arrays according to schedule in the dispassionate scene. The Statistical plan distinguished to the digestive order accompanying t-PA for blood corpuscle and platelet counts confirmed expected evenly right for platelets, but not also for leukocytes.

Author(s) Details:

Michela Crisci,
General Surgery, Faculty of Medicine and Surgery, Vasile Goldis Western University of Arad, 310025 Arad, Romania.

Alessandro Crisci,
School of Medicine, University of Salerno Italy, 84084 Fisciano SA, Italy and Unit of Dermosurgery Cutaneous Transplantations and Hard-to-Heal Wound, 'Villa Fiorita' Private Hospital, 81031 Aversa CE, Italy.

Please see the link here: https://stm.bookpi.org/CERB-V4/article/view/9269

Mesenchymal Stem Cells for Treating Ocular Surface Diseases: A Review | Chapter 01 | Issues and Developments in Medicine and Medical Research Vol. 9

 Background: Ocular surface diseases are one of the most common causes of vision impairment or blindness. In cell therapy and regenerative medicine, mesenchymal stem cells (MSC) have sparked a lot of interest. They are not only widely available, but also have strong differentiating capacities and immunosuppressive qualities. Because of their propensity to evade host immunological rejection, they are commonly employed in allografts. Clinical trials using MSC for the treatment of a variety of disorders that are resistant to conventional therapy are now underway. Several studies have been conducted on the use of MSC in the treatment of corneal abnormalities, with extremely encouraging results.

Critical Issues: Currently, the wide range of MSC isolation and expansion techniques makes it difficult to assess cell treatment ability and establish new treatment regimens.

Future Research: Future research should focus on developing international standards for MSC isolation and characterization. Furthermore, tissue engineering and regenerative medicine techniques for corneal regeneration have shown to be promising. Direct cell/growth factor delivery and hydrogel/non-hydrogel-based scaffolds are the two basic kinds of regenerative methods. We examine current MSC developments in this review, as well as the need for more research to fully realise the potential of an MSC-based cell therapy for treating ocular surface illnesses.

Author(S) Details

Sahar M. M. Omar
Faculty of Medicine, Armed Forces College of Medicine, Ain Shams University, Cairo, Egypt.

View Book:- https://stm.bookpi.org/IDMMR-V9/article/view/5836

New Platelet Concentrates Useful in Tissue Repair. Platelet-rich Fibrin with Leukocytes (L-PRF), Advanced Platelet-Rich Fibrin (A-PRF) and Injectable Platelet-rich Fibrin (i-PRF) | Book Publisher International

 Tissue engineering is a growing multidisciplinary area that tries to regenerate, enhance, or replace predicted damaged or missing tissues for a variety of disorders caused by trauma, disease, and ageing. To ensure that tissue engineering procedures are extensively used in clinical practise, they must be modified so that they are readily available and reasonably simple to utilise in regular clinical practise. To make realistic implementation, the steps between preparation and application must be minimised and optimised. The overall goal is to develop natural platelet concentrates that can be manufactured near to the patient and speed up the implantation procedure while remaining financially feasible for both the patient and the health system. For soft tissue regeneration, fibrin rich in platelets and leukocytes (PRF) and its derivatives (L-PRF, A-PRF, i-PRF) have been employed in a range of medical sectors. In groups evaluated following PRF membrane extraction, almost all platelets (> 97%) are missing from test tubes.

Other cell types involved in tissue repair, such as smooth cell muscles (SMCs) and mesenchymal stem cells, are induced and controlled by growth factors released by platelets found in derivatives of L-PRF (MSCs).

Finally, the findings of this study show that PRF has a good influence on wound healing following surgery.

Author(s) Details

Alessandro Crisci
Department of Medicine, Surgery and Dentistry “Salernitan Medical School”, University of Salerno, Fisciano (SA), Italy and United of Derma Surgery, Skin Transplants and Difficult Wounds, “Villa Fiorita” Nursing Home, Aversa (CE), Italy.

View Book:- https://stm.bookpi.org/NPCUTR/article/view/2100